Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Patients taking Wegovy lose an average of 15 pounds within the first month, with continued reduction reaching 22% of body weight over one year in pivotal trials. The medication works by slowing gastric emptying and signaling satiety to the brain's appetite centers. PlexusDx delivers this same GLP-1 mechanism through compounded semaglutide injections from licensed 503A pharmacies, with pricing that remains flat regardless of dose level.

How Semaglutide Produces Weight Loss Results

Semaglutide, the active ingredient in Wegovy, mimics glucagon-like peptide-1 (GLP-1), a natural hormone that regulates blood sugar and appetite. When injected weekly, it binds to GLP-1 receptors throughout the body, triggering three primary effects: delayed stomach emptying (keeping you full longer), reduced hunger signaling in the hypothalamus, and improved insulin sensitivity. These mechanisms work together to lower calorie intake without requiring extreme dietary restriction or willpower alone.

Clinical data from the STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated that participants on the highest dose lost 22.3% of body weight over 68 weeks, compared to 2.6% in the placebo group. Weight loss typically begins within 4-6 weeks and continues progressively through months 4-6 as the dose increases. This timeline matches the standard dosing protocol used by compounding pharmacies and PlexusDx.

Real-World Weight Loss Outcomes and Timeline

Most patients experience noticeable appetite reduction within days of their first injection, though measurable weight loss on the scale appears after 2-3 weeks. The average first-month loss ranges from 3-8 pounds, accelerating as doses reach therapeutic levels (1.0-2.4 mg weekly). Long-term responders maintain or continue losing weight for 12+ months with consistent use, though results plateau once patients reach their new set point.

Response varies based on genetics, baseline metabolism, diet quality, and exercise patterns. Approximately 85% of users achieve at least 5% weight loss, while about 50% reach the 15%+ reduction threshold. PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R (rs6923761) and GIPR (rs1800437) that influence individual response magnitude, helping optimize medication selection and dosing strategy from month one.

Why Compounded Semaglutide Delivers the Same Clinical Effect

Compounded semaglutide from licensed 503A pharmacies contains the identical active pharmaceutical ingredient as Wegovy and Ozempic, manufactured to USP standards and subject to state pharmacy board oversight. The only meaningful difference is brand name markup and distribution margins—compounding eliminates those costs. PlexusDx sources from verified 503A facilities, ensuring purity, potency, and stability equivalent to brand-name products at a fraction of the price.

Clinical efficacy remains unchanged because weight loss depends on the semaglutide molecule itself, not packaging or supply chain. Whether you use Wegovy ($1,349/mo retail), Ozempic (requiring off-label use for weight loss), or PlexusDx compounded semaglutide starting at $149/mo, the physiological response is identical. Your dose may need to increase over time to maintain results. Your price won't—PlexusDx pricing stays flat across all three commitment tiers.

Comparing Cost, Access, and Personalization Options

Wegovy requires insurance approval, manufacturer assistance programs with income caps, or full out-of-pocket payment at retail prices exceeding $1,000 monthly. PlexusDx eliminates insurance barriers by serving all 50 states with no membership fees, HSA/FSA eligibility, and transparent per-month pricing. Monthly commitments start at $149 for compounded semaglutide injection, supporting doses from 0.25 mg through 2.4 mg without price escalation.

Personalization through PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) maps 14 metabolic pathways and analyzes 49 peptides relevant to weight loss response. Key variants tested include FTO (rs9939609, appetite regulation), MC4R (rs17782313, metabolic rate), GLP1R, and GIPR polymorphisms. This data guides whether semaglutide monotherapy, tirzepatide, or combination approaches (GLP-Squared) maximize your outcomes from the start.

Safety Profile and Managing Common Side Effects

Nausea occurs in 25-40% of semaglutide users during dose escalation and typically resolves within 2-4 weeks as the body adapts. Other common effects include constipation, vomiting, and abdominal discomfort—all mild-to-moderate and manageable through slower titration, dietary fiber, hydration, and ginger supplementation. Serious adverse events (pancreatitis, thyroid cancer) remain exceedingly rare and have not shown increased incidence in semaglutide trials versus placebo.

Contraindications include personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2). Patients with diabetic retinopathy or severe kidney disease require monitoring. PlexusDx requires a physician consultation before dispensing, ensuring medical history review and personalized safety clearance. Starting at the lowest dose (0.25 mg) and titrating over 16 weeks minimizes side effects while maximizing tolerance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight do most people lose using semaglutide?

Clinical trials show an average of 15-22% body weight reduction over one year at therapeutic doses. Most patients lose 3-8 pounds in the first month, with acceleration through months 2-6. Individual results depend on dose, adherence, diet quality, and genetic factors that PlexusDx can assess through peptide testing.

Is compounded semaglutide from PlexusDx as effective as Wegovy?

Yes. Both contain the same FDA-approved semaglutide molecule. Compounded semaglutide from licensed 503A pharmacies meets identical USP purity standards. Weight loss outcomes depend on the active ingredient, not the brand name or package—PlexusDx delivers clinical equivalence at significantly lower cost.

What is the monthly cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injection starts at $149/mo and remains flat across all dosing levels—whether you're at 0.25 mg or 2.4 mg. No insurance is required, and the medication is HSA/FSA eligible. Three commitment tiers offer additional savings for quarterly or annual prepayment.

What side effects should I expect with semaglutide?

Nausea (25-40%), constipation, and mild abdominal discomfort are most common during dose escalation and typically resolve within 2-4 weeks. Slow titration starting at 0.25 mg and adequate hydration minimize these effects. Serious side effects are rare. Always discuss medical history with your PlexusDx physician before starting.

How does the Precision Peptide Genetic Test improve my weight loss results?

The test ($99 add-on) identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence semaglutide response and metabolism. Results guide personalized dosing, medication selection (semaglutide vs. tirzepatide), and combination therapy optimization—helping you achieve maximum weight loss from month one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves